The eczema Priority Setting Partnership: A collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of Eczema

British Journal of Dermatology

Volumn 168, Issue 3, 2013, Pages 577-582

  Batchelor, J M ^a   Ridd, M J ^b   Clarke, T ^a   Ahmed, A ^c   Cox, M ^d   Crowe, S ^e   Howard, M ^c   Lawton, S ^f   McPhee, M ^a   Rani, A ^c   Ravenscroft, J C ^f   Roberts, A ^c   Thomas, K S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Patient Representative   (United Kingdom)

^d NATIONAL ECZEMA SOCIETY   (United Kingdom)

^e James Lind Alliance   (United Kingdom)

^f NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CAREGIVER; COOPERATION; ECZEMA; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PATIENT PARTICIPATION; PERSONNEL; PUBLIC RELATIONS; SELF HELP; UNCERTAINTY;

ATTITUDE TO HEALTH; BIOMEDICAL RESEARCH; CAREGIVERS; COOPERATIVE BEHAVIOR; ECZEMA; HEALTH PERSONNEL; HEALTH PRIORITIES; HUMANS; INTERPROFESSIONAL RELATIONS; PATIENT PARTICIPATION; RESEARCH PERSONNEL; SELF-HELP GROUPS; UNCERTAINTY;

EID: 84882262572     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12040     Document Type: Article

References (24)

1. Odhiambo J, Williams H, Clayton T et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009;124:1251-8.
2. Williams H, Stewart A, von Mutius E et al. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008;121:947-54.
3. Meltzer LJ, Moore M. Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. J Pediatr Psychol 2008;33:279-91.
4. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008;25:1-6.
5. Shams K, Grindlay DJ, Williams HC. What's new in atopic eczema? An analysis of systematic reviews published in 2009-2010. Clin Exp Dermatol 2011;36:573-7.
6. Batchelor JM, Grindlay DJ, Williams HC. What's new in atopic eczema? An analysis of systematic reviews published in 2008 and 2009. Clin Exp Dermatol 2010;35:823-7.
7. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4:1-191.
8. Nankervis H, Maplethorpe A, Williams HC. Mapping randomized controlled trials of treatments for eczema - the GREAT database (the Global Resource of EczemA Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010). BMC Dermatol 2011;18:10.
9. Thomas KS, Dean T, O'Leary C et al. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med 2011;8:e1000395.
10. Schuttelaar ML, Vermeulen KM, Coenraads PJ. Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs. Br J Dermatol 2011;165:600-11.
11. Hindley D, Galloway G, Murray J et al. A randomised study of 'wet wraps' vs. conventional treatment for atopic eczema. Arch Dis Child 2006;91:164-8.
12. Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years. Available at: http://www.nice.org.uk/CG057 (last accessed 21 September 2012).
13. NHS Evidence - UK Database of Uncertainties about the Effects of Treatment (DVETs). Available at: http://www.library.nhs.uk/duets (last accessed 21 September 2012).
14. Oliver S, Clarke-Jones L, Rees R et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess 2004;8:1-148, III-IV.
15. Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000;355:2037-40.
16. Chalmers I. Well-informed uncertainties about the effects of treatments. BMJ 2004;328:475-6.
17. Eleftheriadou V, Whitton ME, Gawkrodger DJ et al. Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol 2011;164:530-6.
18. James Lind Alliance. The James Lind Alliance Guidebook (version 4). Oxford: James Lind Alliance, 2012. Available at: http://www.jlaguidebook.org (last accessed 21 September 2012).
19. Buckley B, Grant AM, Firkins L et al. Working together to identify research questions. Continence UK 2007;1:76-81.
20. Aldridge A, Levine K. Surveying the Social World: Principles and Practice in Survey Research. Buckingham: Open University Press, 2001.
21. Grey DE. Doing Research in the Real World. London: Sage Publications, 2004.
22. Frequency of application of topical corticosteroids for atopic eczema. Available at: http://www.nice.org.uk/TA081guidance (last accessed 21 September 2012).
23. Scottish Intercollegiate Guidelines Network (SIGN). Management of Atopic Eczema in Primary Care. Edinburgh: SIGN, 2011 (SIGN publication no. 125). Available at: http://www.sign. ac.uk (last accessed 21 September 2012).
24. Eccles MP, Armstrong D, Baker R et al. An implementation research agenda. Implement Sci 2009;7:18.